| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Galectin Therapeutics Inc (GALT) has 14 insiders with recent SEC Form 4 filings, including 10 buys and 3 sells. GALT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 10.33M | $21.70M | - | |
| 10% | 5.61M | $11.79M | - | |
| CFO | 100.0K | $210.0K | - | |
| CEO | 100.0K | $210.0K | - | |
| Other | 100.0K | $210.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 24, 2024 | Freeman Kevin D56 | Director | Buy | 10,000 | $0.81 | $8,134.00 | +28.8% | +96.3% | +379.4% | |
| Dec 24, 2024 | Zordani Richard A. Jr.52 | Director | Buy | 10,000 | $0.82 | $8,164.00 | +31.2% | +96.3% | +379.4% | |
| Dec 24, 2024 | Eldred Kary80 | Director | Buy | 13,469 | $0.82 | $11,044.58 | +26.8% | +96.3% | +379.4% | |
| Dec 23, 2024 | Lewis Joel59 | President And CEO | Sale+OE | 56,000 | $0.89 | $49,610.40 | -5.9% | +85.4% | +348.3% | |
| Dec 23, 2024 | Jamil Khurram | Chief Medical Officer | Sale+OE | 13,654 | $0.88 | $12,044.19 | -34.1% | +85.4% | +348.3% | |
| Dec 23, 2024 | Callicutt Jack W62 | Chief Financial Officer | Sale+OE | 40,000 | $0.89 | $35,492.00 | -84.0% | +85.4% | +348.3% | |
| Oct 23, 2024 | Eldred Kary80 | Director | Buy | 500 | $2.60 | $1,300.00 | +1.0% | -52.3% | +98.8% | |
| Oct 17, 2024 | Freeman Kevin D56 | Director | Buy | 1,300 | $2.64 | $3,432.00 | +3.9% | -51.9% | +87.6% | |
| Oct 16, 2024 | Freeman Kevin D56 | Director | Buy | 10,000 | $2.70 | $27,000.00 | +9.7% | -56.3% | +92.0% | |
| Aug 23, 2024 | Zordani Richard A. Jr.52 | Director | Buy | 3,500 | $2.30 | $8,050.00 | +5.7% | +17.7% | +77.5% |